Flea drug resistance evaluation method and related device

Through multi-dimensional feature extraction of flea habit characteristics and drug trial data and neural network model training, a drug resistance evaluation model was established, which solved the problems of low efficiency and poor accuracy in the existing technology, and achieved more accurate drug resistance evaluation and Adjust prevention and control strategies.

CN118942551APending Publication Date: 2024-11-12QINGHAI PROVINCIAL INST FOR ENDEMIC DISEASE CONTROL & PREVENTION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410971688.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is inefficient and difficult to guarantee the accuracy in the assessment of flea drug resistance, and the lack of comprehensive consideration of the comprehensive characteristics of fleas, resulting in errors in prevention and control measures and waste of resources.

Method used

Through multi-dimensional feature extraction based on flea habit characteristics and drug trial data, combined with neural network model training, a drug resistance evaluation model is established and the degree of resistance is inferred.

Benefits of technology

It improves the accuracy and efficiency of drug resistance assessment, can deeply reveal the causes and rules of resistance, provide support for timely adjustment of prevention and treatment strategies, reduce drug abuse and reduce prevention and treatment costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118942551A_ABST
    Figure CN118942551A_ABST
Patent Text Reader

Abstract

The invention discloses a flea drug resistance evaluation method, a flea drug resistance evaluation device, resistance evaluation equipment and a computer readable storage medium. The method comprises the following steps: performing data acquisition based on flea habit characteristics and drug test data to obtain sample original data; performing multi-dimensional feature extraction on the sample original data based on the drug resistance factors to obtain sample features; taking the sample features as the input of an initial neural network model, taking the drug experiment data as the output of the initial neural network model, and adopting the sample features to carry out model training on the initial neural network model to obtain a drug resistance evaluation model; and performing reasoning processing on the characteristic data of the to-be-detected medicine by adopting the medicine resistance evaluation model to obtain resistance degree data. The accuracy and efficiency of flea drug resistance evaluation are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of computer technology, and more specifically, relates to a flea drug resistance evaluation method, a flea drug resistance evaluation device, a resistance evaluation equipment and a computer-readable storage medium. Background Art

[0002] Fleas are common and stubborn parasites that have long plagued the health of humans and animals. In the process of flea control, the use of drugs is one of the main means. However, with the passage of time and the widespread use of drugs, fleas have gradually developed resistance to drugs, which has greatly reduced the effectiveness of traditional drug control.

[0003] In related technologies, the evaluation methods for flea drug resistance usually rely on limited experimental data and manual observation, which is not only inefficient but also difficult to ensure accuracy. Some studies only focus on some physiological characteristics of fleas or single environmental factors, lacking a comprehensive consideration of the comprehensive characteristics of fleas. Existing evaluation technologies are often unable to accurately predict drug resistance when faced with complex flea populations and changing environmental conditions, resulting in errors in prevention and control measures and waste of resources.

[0004] Therefore, how to improve the accuracy and efficiency of flea drug resistance assessment is a key issue that technicians in this field are concerned about. Summary of the invention

[0005] The purpose of the present application is to provide a flea drug resistance assessment method, a flea drug resistance assessment device, a resistance assessment equipment and a computer-readable storage medium to improve the accuracy and efficiency of flea drug resistance assessment.

[0006] In view of the above defects or improvement needs of the prior art, the present invention provides a method for evaluating flea drug resistance, comprising:

[0007] Data collection is performed based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data;

[0008] Performing multi-dimensional feature extraction on the sample original data based on drug resistance factors to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction;

[0009] Using the sample features as input of an initial neural network model, using the drug experimental data as output of the initial neural network model, and using the sample features to perform model training on the initial neural network model to obtain a drug resistance assessment model;

[0010] The drug resistance assessment model is used to perform inference processing on the characteristic data of the drug to be tested to obtain resistance degree data.

[0011] Optionally, data collection is performed based on flea habit characteristics and drug test data to obtain sample raw data, including:

[0012] Collecting sample information of the collected samples to obtain the sample information; wherein the sample information includes: collection location information, host species information, drug use history information, morphological information, biochemical index information, gene point information, and environmental information;

[0013] Acquire experimental data of drug sensitivity test of each sample; wherein the experimental data include: flea survival status and reproductive capacity data;

[0014] The microbial community data of the environment of each of the samples is collected.

[0015] Optionally, multi-dimensional feature extraction is performed on the sample original data based on drug resistance factors to obtain sample features, including:

[0016] Extracting morphological features from the original data of the sample to obtain body length features, body width features, antenna length features, and leg segment length features;

[0017] Extracting physiological characteristics from the raw data of the samples to obtain enzyme activity characteristics, hormone level characteristics, and drug metabolite concentration characteristics;

[0018] Extracting gene features from the original sample data to obtain gene locus features;

[0019] Extracting environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features;

[0020] Extracting microbial features from the original sample data to obtain microbial species features and microbial quantity features;

[0021] The body length characteristics, the body width characteristics, the antenna length characteristics, the leg segment length characteristics, the enzyme activity characteristics, the hormone level characteristics, the drug metabolite concentration characteristics, the gene point characteristics, the temperature characteristics, the humidity characteristics, the light intensity characteristics, the microorganism species characteristics, and the microorganism quantity characteristics are used as the sample characteristics.

[0022] Optionally, also include:

[0023] The drug resistance assessment model is optimized and trained using cross-validation technology to obtain an optimized drug resistance assessment model.

[0024] The present application also provides a flea drug resistance assessment device, comprising:

[0025] A data collection module is used to collect data based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data;

[0026] A feature extraction module, used to perform multi-dimensional feature extraction on the sample original data based on drug resistance factors to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction;

[0027] A model training module, used to use the sample features as input of an initial neural network model, use the drug experimental data as output of the initial neural network model, and use the sample features to perform model training on the initial neural network model to obtain a drug resistance assessment model;

[0028] The model reasoning module is used to use the drug resistance assessment model to perform reasoning processing on the characteristic data of the drug to be detected to obtain resistance degree data.

[0029] Optionally, the data acquisition module is specifically used to collect sample information of the collected samples to obtain the sample information; wherein the sample information includes: collection location information, host type information, drug use history information, morphological information, biochemical indicator information, gene point information, and environmental information; obtain experimental data of drug sensitivity experiments for each of the samples; wherein the experimental data includes: flea survival status and reproductive capacity data; and collect the microbial community data of the environment of each of the samples.

[0030] Optionally, the feature extraction module is specifically used to extract morphological features from the sample raw data to obtain body length features, body width features, antennae length features, and leg segment length features; to extract physiological features from the sample raw data to obtain enzyme activity features, hormone level features, and drug metabolite concentration features; to extract gene features from the sample raw data to obtain gene point features; to extract environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features; to extract microbial features from the sample raw data to obtain microbial species features and microbial quantity features; and use the body length features, the body width features, the antennae length features, the leg segment length features, the enzyme activity features, the hormone level features, the drug metabolite concentration features, the gene point features, the temperature features, the humidity features, the light intensity features, the microbial species features, and the microbial quantity features as the sample features.

[0031] Optionally, also include:

[0032] The model optimization module is used to optimize the training of the drug resistance assessment model by using cross-validation technology to obtain an optimized drug resistance assessment model.

[0033] The present application also provides a resistance evaluation device, comprising:

[0034] Memory for storing computer programs;

[0035] A processor is used to implement the steps of the flea drug resistance assessment method as described above when executing the computer program.

[0036] The present application also provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the steps of the flea drug resistance assessment method as described above are implemented.

[0037] A flea drug resistance assessment method provided in the present application includes: collecting data based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data; performing multidimensional feature extraction on the sample original data based on drug resistance factors to obtain sample features; wherein the multidimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction; using the sample features as the input of an initial neural network model, using the drug test data as the output of the initial neural network model, and using the sample features to train the initial neural network model to obtain a drug resistance assessment model; using the drug resistance assessment model to perform inference processing on the feature data of the drug to be tested to obtain resistance degree data.

[0038] It has the following beneficial effects:

[0039] First, through comprehensive data collection based on flea habits and drug test data, the completeness and accuracy of the evaluation basis were ensured, avoiding evaluation errors caused by missing or biased data, and laying a solid foundation for subsequent accurate evaluation.

[0040] Multidimensional feature extraction covers multiple aspects of fleas' morphology, physiology, genes, environment, and microorganisms. It can deeply explore the complex mechanisms of flea drug resistance, thereby more accurately revealing the causes and laws of resistance, greatly improving the reliability and scientificity of the evaluation.

[0041] The drug resistance assessment model obtained by training the initial neural network model fully leverages the advantages of neural networks in processing complex data and nonlinear relationships, enabling the model to accurately capture the subtle relationship between sample characteristics and drug resistance, significantly improving the accuracy and predictive ability of the assessment.

[0042] Finally, the drug resistance assessment model is used to infer the characteristic data of the tested drugs, which can quickly obtain resistance degree data, provide strong support for timely adjustment of flea control strategies, help improve control effects, reduce drug abuse, reduce control costs, and protect the health of humans and animals. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying any creative work.

[0044] Figure 1 A flow chart of a method for evaluating flea drug resistance provided in an embodiment of the present application;

[0045] Figure 2 A schematic diagram of the structure of a flea drug resistance assessment device provided in an embodiment of the present application;

[0046] Figure 3 This is a schematic diagram of the structure of the resistance evaluation device provided in an embodiment of the present application. DETAILED DESCRIPTION

[0047] The core of this application is to provide a flea drug resistance assessment method, a flea drug resistance assessment device, a resistance assessment equipment and a computer-readable storage medium to improve the accuracy and efficiency of flea drug resistance assessment.

[0048] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0049] The following is an example to illustrate the flea drug resistance assessment method provided in the present application.

[0050] Please refer to Figure 1 , Figure 1This is a flow chart of a method for evaluating flea drug resistance provided in an embodiment of the present application.

[0051] In this embodiment, the method may include:

[0052] S101, collecting data based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data.

[0053] In this step, a large number of flea samples can be collected, covering different geographical regions and different host sources. During the collection process, the relevant information of each sample is recorded, such as the collection location, host type, drug use history, etc. Then, a drug sensitivity test is performed on each sample to obtain data such as flea survival and reproductive capacity after the drug is applied. At the same time, the microbial community data in the environment where the flea samples are located is collected.

[0054] It can be seen that in this step, the living habits and characteristics of fleas are fully understood, and original data including sample information (such as source, host, etc.), drug experimental data (such as reactions under different drugs), and microbial community data are collected in a targeted manner. Comprehensive and accurate data collection provides a rich basis for subsequent analysis and evaluation, avoids the one-sidedness and limitations of the data, and helps to more comprehensively understand the situation of flea drug resistance.

[0055] Furthermore, this step may include:

[0056] Step 1, collecting sample information of the collected samples to obtain sample information; wherein the sample information includes: collection location information, host species information, drug use history information, morphological information, biochemical index information, gene point information, and environmental information;

[0057] Step 2, obtaining experimental data of drug sensitivity test for each sample; wherein the experimental data includes: flea survival status and reproductive capacity data;

[0058] Step 3, collect microbial community data of the environment of each sample.

[0059] S102, performing multi-dimensional feature extraction on the sample original data based on the drug resistance factor to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction;

[0060] Based on S101, this step aims to illustrate how to extract more reasonable data features. In this step, morphological features: measure morphological indicators such as body length, body width, antenna length, leg length, etc. of fleas; observe the texture, color and hair growth of the flea body surface.

[0061] Physiological characteristics: Analyze the blood biochemical indicators of fleas, such as enzyme activity, hormone levels, etc.; detect the concentration of drug metabolites in fleas.

[0062] Gene characteristics: Gene sequencing technology is used to obtain gene locus information related to drug resistance and analyze gene mutations and expression levels.

[0063] Environmental characteristics: record the temperature, humidity, light intensity, etc. of the flea living environment; analyze the chemical composition in the environment.

[0064] Microbial characterization: Identify the types and quantities of microorganisms that coexist or parasitize with fleas and study their association with drug resistance.

[0065] It can be seen that this step conducts in-depth analysis and refinement of the original data from multiple dimensions, covering flea morphology (such as size, shape, etc.), physiology (such as biochemical indicators, metabolic conditions), genes (such as mutations and expressions of related genes), environment (such as temperature, humidity, etc.) and interactions with microorganisms. Multidimensional feature extraction can reveal the potential mechanism of flea drug resistance in more detail, help discover subtle resistance factors, and improve the accuracy and reliability of the assessment.

[0066] Furthermore, this step may include:

[0067] Step 1, extracting morphological features of the sample raw data to obtain body length features, body width features, antenna length features, and leg segment length features;

[0068] Step 2, extracting physiological characteristics of the sample raw data to obtain enzyme activity characteristics, hormone level characteristics, and drug metabolite concentration characteristics;

[0069] Step 3, extracting gene features from the original sample data to obtain gene locus features;

[0070] Step 4, extracting environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features;

[0071] Step 5, extracting microbial features from the original sample data to obtain microbial species features and microbial quantity features;

[0072] Step 6, taking body length characteristics, body width characteristics, antenna length characteristics, leg segment length characteristics, enzyme activity characteristics, hormone level characteristics, drug metabolite concentration characteristics, gene point characteristics, temperature characteristics, humidity characteristics, light intensity characteristics, microbial species characteristics, and microbial quantity characteristics as sample characteristics.

[0073] S103, using the sample features as the input of the initial neural network model, using the drug experimental data as the output of the initial neural network model, and using the sample features to perform model training on the initial neural network model to obtain a drug resistance assessment model;

[0074] Based on S102, this step aims to use sample features as the input of the initial neural network model, drug experimental data as the output of the initial neural network model, and use sample features to train the initial neural network model to obtain a drug resistance assessment model. Among them, other machine learning algorithms can be selected, such as random forest, support vector machine, neural network. Consider using ensemble learning methods to fuse the prediction results of multiple models to improve the reliability of the assessment.

[0075] It can be seen that the extracted sample features are input into the initial neural network model, and the drug experimental data is used as the expected output result. By continuously adjusting the parameters of the model, it can learn the complex relationship between sample features and drug resistance. The powerful learning ability and nonlinear fitting ability of the neural network can handle complex multi-factor relationships, thereby establishing an accurate drug resistance assessment model and providing technical support for accurate assessment.

[0076] S104, using a drug resistance assessment model to perform inference processing on characteristic data of the drug to be tested to obtain resistance degree data.

[0077] Based on S103, this step aims to use the drug resistance assessment model to perform inference processing on the characteristic data of the drug to be tested to obtain resistance degree data.

[0078] It can be seen that in this step, the characteristic data of the flea sample to be evaluated under a specific drug is input into the already trained evaluation model, and the resistance degree of the sample to the drug is obtained through the calculation and reasoning of the model. Obviously, this step can quickly and efficiently provide accurate drug resistance evaluation results for new flea samples, provide timely and targeted decision-making basis for actual flea control work, and improve the control effect and efficiency.

[0079] Furthermore, this embodiment may also include:

[0080] The cross-validation technology was used to optimize the training of the drug resistance assessment model to obtain the optimized drug resistance assessment model.

[0081] It can be seen that this optional solution can improve the accuracy and generalization ability of the model.

[0082] In summary, this embodiment ensures the completeness and accuracy of the evaluation basis by conducting comprehensive data collection based on flea habit characteristics and drug test data, avoids evaluation errors caused by data missing or bias, and lays a solid foundation for subsequent accurate evaluation.

[0083] Multidimensional feature extraction covers multiple aspects of fleas' morphology, physiology, genes, environment, and microorganisms. It can deeply explore the complex mechanisms of flea drug resistance, thereby more accurately revealing the causes and laws of resistance, greatly improving the reliability and scientificity of the evaluation.

[0084] The drug resistance assessment model obtained by training the initial neural network model fully leverages the advantages of neural networks in processing complex data and nonlinear relationships, enabling the model to accurately capture the subtle relationship between sample characteristics and drug resistance, significantly improving the accuracy and predictive ability of the assessment.

[0085] Finally, the drug resistance assessment model is used to infer the characteristic data of the tested drugs, which can quickly obtain resistance degree data, provide strong support for timely adjustment of flea control strategies, help improve control effects, reduce drug abuse, reduce control costs, and protect the health of humans and animals.

[0086] Furthermore, the flea drug resistance assessment method provided in the present application is further described below through another specific embodiment.

[0087] In this embodiment, 1000 flea samples from different regions were selected, covering a variety of hosts such as cats, dogs, rabbits, etc. The collection location, host information, drug use history, and temperature and humidity of the environment of each flea were recorded in detail.

[0088] The flea samples were measured for morphological characteristics, including an average body length of 2.5 mm, an average body width of 1.2 mm, and antenna lengths ranging from 1.8 to 2.3 mm. Their blood biochemical indicators, such as the activity level of specific enzymes, were tested. Gene sequencing was used to obtain information on gene loci related to drug resistance, and high-frequency mutations were found in some genes. At the same time, the chemical composition and the types and numbers of symbiotic microorganisms in the environment were analyzed.

[0089] The extracted multi-dimensional features are input into the model built based on the random forest algorithm for training. After cross-validation and parameter optimization, the model achieves an accuracy of 90%, a recall of 85%, and an F1 value of 87.5% on an independent test set.

[0090] For example, for a flea sample from a specific area, whose host is a cat and has been treated with a common flea medicine, after entering its various characteristics, the system will assess that the flea has moderate resistance to the drug and give corresponding prevention and control recommendations, such as changing the type of drug or adjusting the dosage.

[0091] In actual application, the evaluation system is deployed as a web-based application. Users only need to upload relevant information of flea samples online, and the system can quickly give accurate drug resistance evaluation results and professional suggestions. After a period of use, user feedback is collected to further optimize the model and system functions.

[0092] Through this example, the effectiveness and practicality of the artificial intelligence-based flea drug resistance assessment technical solution are demonstrated, which can provide strong support and guidance for flea control work.

[0093] The following is an introduction to the flea drug resistance assessment device provided in an embodiment of the present application. The flea drug resistance assessment device and the flea drug resistance assessment method described below can be referenced to each other.

[0094] Please refer to Figure 2 , Figure 2 This is a schematic diagram of the structure of a flea drug resistance assessment device provided in an embodiment of the present application.

[0095] In this embodiment, the device may include:

[0096] The data collection module 100 is used to collect data based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data;

[0097] The feature extraction module 200 is used to perform multi-dimensional feature extraction on the sample original data based on the drug resistance factor to obtain the sample feature; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction;

[0098] The model training module 300 is used to use the sample features as the input of the initial neural network model, use the drug experimental data as the output of the initial neural network model, use the sample features to perform model training on the initial neural network model, and obtain a drug resistance assessment model;

[0099] The model reasoning module 400 is used to use the drug resistance assessment model to perform reasoning processing on the characteristic data of the drug to be tested to obtain resistance degree data.

[0100] Optionally, a data collection module is specifically used to collect sample information of the collected samples to obtain sample information; wherein the sample information includes: collection location information, host species information, drug use history information, morphological information, biochemical indicator information, gene point information, and environmental information; obtain experimental data of drug sensitivity experiments for each sample; wherein the experimental data includes: flea survival status, reproductive capacity data; collect microbial community data of the environment of each sample.

[0101] Optionally, a feature extraction module is specifically used to extract morphological features from the sample raw data to obtain body length features, body width features, antennae length features, and leg segment length features; to extract physiological features from the sample raw data to obtain enzyme activity features, hormone level features, and drug metabolite concentration features; to extract gene features from the sample raw data to obtain gene point features; to extract environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features; to extract microbial features from the sample raw data to obtain microbial species features and microbial quantity features; and to use body length features, body width features, antennae length features, leg segment length features, enzyme activity features, hormone level features, drug metabolite concentration features, gene point features, temperature features, humidity features, light intensity features, microbial species features, and microbial quantity features as sample features.

[0102] Optionally, also include:

[0103] The model optimization module is used to optimize the training of the drug resistance assessment model using cross-validation technology to obtain an optimized drug resistance assessment model.

[0104] This application also provides resistance evaluation equipment, please refer to Figure 3 , Figure 3 This is a schematic diagram of the structure of a resistance evaluation device provided in an embodiment of the present application. The resistance evaluation device may include:

[0105] Memory for storing computer programs;

[0106] A processor, when used to execute a computer program, can implement the steps of any of the above-mentioned flea drug resistance assessment methods.

[0107] like Figure 3 FIG. 1 is a schematic diagram of the composition structure of the resistance evaluation device, which may include: a processor 10, a memory 11, a communication interface 12 and a communication bus 13. The processor 10, the memory 11 and the communication interface 12 communicate with each other through the communication bus 13.

[0108] In the embodiment of the present application, the processor 10 may be a central processing unit (CPU), an application specific integrated circuit, a digital signal processor, a field programmable gate array or other programmable logic devices.

[0109] The processor 10 may call a program stored in the memory 11. Specifically, the processor 10 may execute operations in an embodiment of the abnormal IP identification method.

[0110] The memory 11 is used to store one or more programs, which may include program codes, and the program codes include computer operation instructions. In the embodiment of the present application, the memory 11 at least stores programs for implementing the following functions:

[0111] Data collection is performed based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data;

[0112] Based on drug resistance factors, multi-dimensional feature extraction is performed on the original data of the sample to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction;

[0113] The sample features are used as the input of the initial neural network model, the drug experimental data are used as the output of the initial neural network model, and the sample features are used to train the initial neural network model to obtain a drug resistance assessment model;

[0114] The drug resistance assessment model is used to infer the characteristic data of the drug to be tested to obtain the resistance degree data.

[0115] In a possible implementation, the memory 11 may include a program storage area and a data storage area, wherein the program storage area may store an operating system and an application required for at least one function, etc.; the data storage area may store data created during use.

[0116] In addition, the memory 11 may include a high-speed random access memory, and may also include a non-volatile memory, such as at least one disk storage device or other volatile solid-state storage device.

[0117] The communication interface 12 may be an interface of a communication module, and is used to connect to other devices or systems.

[0118] Of course, it should be noted that Figure 3 The structure shown does not constitute a limitation on the resistance evaluation device in the embodiment of the present application. In actual applications, the resistance evaluation device may include Figure 3More or fewer components than shown, or combinations of certain components.

[0119] The present application also provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor, the steps of any of the above-mentioned flea drug resistance assessment methods can be implemented.

[0120] The computer-readable storage medium may include: a USB flash drive, a mobile hard disk, a read-only memory (ROM), a random access memory (RAM), a magnetic disk or an optical disk, and other media that can store program codes.

[0121] For an introduction to the computer-readable storage medium provided in this application, please refer to the above method embodiment, and this application will not go into details here.

[0122] The various embodiments in the specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referred to each other. For the device disclosed in the embodiment, since it corresponds to the method disclosed in the embodiment, the description is relatively simple, and the relevant parts can be referred to the method part.

[0123] Professionals may further appreciate that the units and algorithm steps of each example described in conjunction with the embodiments disclosed herein can be implemented in electronic hardware, computer software, or a combination of the two. In order to clearly illustrate the interchangeability of hardware and software, the composition and steps of each example have been generally described in the above description according to function. Whether these functions are performed in hardware or software depends on the specific application and design constraints of the technical solution. Professionals and technicians may use different methods to implement the described functions for each specific application, but such implementation should not be considered to be beyond the scope of this application.

[0124] The steps of the method or algorithm described in conjunction with the embodiments disclosed herein may be implemented directly using hardware, a software module executed by a processor, or a combination of the two. The software module may be placed in a random access memory (RAM), a memory, a read-only memory (ROM), an electrically programmable ROM, an electrically erasable programmable ROM, a register, a hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art.

[0125] The above is a detailed introduction to a flea drug resistance assessment method, a flea drug resistance assessment device, a resistance assessment equipment and a computer-readable storage medium provided by the present application. This article uses specific examples to illustrate the principles and implementation methods of the present application. The description of the above embodiments is only used to help understand the method of the present application and its core idea. It should be pointed out that for ordinary technicians in this technical field, without departing from the principles of the present application, several improvements and modifications can be made to the present application, and these improvements and modifications also fall within the scope of protection of the claims of the present application.

Claims

1. A method for evaluating flea drug resistance, characterized in that: include: Data collection is performed based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data; Performing multi-dimensional feature extraction on the sample original data based on drug resistance factors to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction; Using the sample features as input of an initial neural network model, using the drug experimental data as output of the initial neural network model, and using the sample features to perform model training on the initial neural network model to obtain a drug resistance assessment model; The drug resistance assessment model is used to perform inference processing on the characteristic data of the drug to be tested to obtain resistance degree data.

2. The method for evaluating flea drug resistance according to claim 1, characterized in that: Data collection is carried out based on flea habit characteristics and drug test data to obtain sample raw data, including: Collecting sample information of the collected samples to obtain the sample information; wherein the sample information includes: collection location information, host species information, drug use history information, morphological information, biochemical index information, gene point information, and environmental information; Acquire experimental data of drug sensitivity test of each sample; wherein the experimental data include: flea survival status and reproductive capacity data; The microbial community data of the environment of each of the samples is collected.

3. The method for evaluating flea drug resistance according to claim 1, characterized in that: Based on the drug resistance factors, multi-dimensional feature extraction is performed on the sample original data to obtain sample features, including: Extracting morphological features from the original data of the sample to obtain body length features, body width features, antenna length features, and leg segment length features; Extracting physiological characteristics from the raw data of the samples to obtain enzyme activity characteristics, hormone level characteristics, and drug metabolite concentration characteristics; Extracting gene features from the original sample data to obtain gene locus features; Extracting environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features; Extracting microbial features from the original sample data to obtain microbial species features and microbial quantity features; The body length characteristics, the body width characteristics, the antenna length characteristics, the leg segment length characteristics, the enzyme activity characteristics, the hormone level characteristics, the drug metabolite concentration characteristics, the gene point characteristics, the temperature characteristics, the humidity characteristics, the light intensity characteristics, the microorganism species characteristics, and the microorganism quantity characteristics are used as the sample characteristics.

4. The method for evaluating flea drug resistance according to claim 1, characterized in that: Also includes: The drug resistance assessment model is optimized and trained using cross-validation technology to obtain an optimized drug resistance assessment model.

5. A flea drug resistance assessment device, characterized in that: include: A data collection module is used to collect data based on flea habit characteristics and drug test data to obtain sample original data; wherein the sample original data includes: sample information, drug test data, and microbial community data; A feature extraction module, used to perform multi-dimensional feature extraction on the sample original data based on drug resistance factors to obtain sample features; wherein the multi-dimensional feature extraction includes: morphological feature extraction, physiological feature extraction, gene feature extraction, environmental feature extraction, and microbial feature extraction; A model training module, used to use the sample features as input of an initial neural network model, use the drug experimental data as output of the initial neural network model, and use the sample features to perform model training on the initial neural network model to obtain a drug resistance assessment model; The model reasoning module is used to use the drug resistance assessment model to perform reasoning processing on the characteristic data of the drug to be detected to obtain resistance degree data.

6. The flea drug resistance evaluation device according to claim 5, characterized in that: The data acquisition module is specifically used to collect sample information of the collected samples to obtain the sample information; wherein the sample information includes: collection location information, host type information, drug use history information, morphological information, biochemical indicator information, gene point information, and environmental information; obtain experimental data of drug sensitivity experiments for each of the samples; wherein the experimental data includes: flea survival status and reproductive capacity data; collect the microbial community data of the environment of each of the samples.

7. The flea drug resistance evaluation device according to claim 5, characterized in that: The feature extraction module is specifically used to extract morphological features from the sample raw data to obtain body length features, body width features, antenna length features, and leg segment length features; Extracting physiological characteristics from the raw data of the samples to obtain enzyme activity characteristics, hormone level characteristics, and drug metabolite concentration characteristics; Extracting gene features from the original sample data to obtain gene locus features; Extracting environmental features from the sample raw data to obtain temperature features, humidity features, and light intensity features; Microbial characteristics are extracted from the original data of the sample to obtain microbial species characteristics and microbial quantity characteristics; the body length characteristics, the body width characteristics, the antenna length characteristics, the leg segment length characteristics, the enzyme activity characteristics, the hormone level characteristics, the drug metabolite concentration characteristics, the gene point characteristics, the temperature characteristics, the humidity characteristics, the light intensity characteristics, the microbial species characteristics, and the microbial quantity characteristics are used as the sample characteristics.

8. The flea drug resistance evaluation device according to claim 5, characterized in that: Also includes: The model optimization module is used to optimize the training of the drug resistance assessment model by using cross-validation technology to obtain an optimized drug resistance assessment model.

9. A resistance evaluation device, characterized in that: include: Memory for storing computer programs; A processor, for implementing the steps of the flea drug resistance assessment method according to any one of claims 1 to 4 when executing the computer program.

10. A computer-readable storage medium, characterized in that: The computer-readable storage medium stores a computer program, and when the computer program is executed by a processor, the steps of the flea drug resistance assessment method as described in any one of claims 1 to 4 are implemented.